scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1045507585 |
P356 | DOI | 10.1038/NM.1880 |
P3181 | OpenCitations bibliographic resource ID | 617854 |
P698 | PubMed publication ID | 18931683 |
P5875 | ResearchGate publication ID | 23395274 |
P50 | author | Mauro Biffoni | Q37391458 |
Maria Musumeci | Q42843538 | ||
Désirée Bonci | Q43132273 | ||
Ruggero De Maria | Q64679020 | ||
P2093 | author name string | Cesare Peschle | |
Lorenzo Memeo | |||
Catherine Labbaye | |||
Valeria Coppola | |||
Leonardo D'Urso | |||
Giovanni Muto | |||
Monica Bartucci | |||
Raffaella Giuffrida | |||
Alfredo Pagliuca | |||
Antonio Addario | |||
P2860 | cites work | Human MicroRNA targets | Q21563637 |
miR-15 and miR-16 induce apoptosis by targeting BCL2 | Q24536069 | ||
Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 | ||
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers | Q24625794 | ||
Prediction of mammalian microRNA targets | Q27860498 | ||
Combinatorial microRNA target predictions | Q27860510 | ||
Oncomirs - microRNAs with a role in cancer | Q27860773 | ||
Wnt/beta-catenin signaling in development and disease | Q27860784 | ||
Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets | Q27860792 | ||
Silencing of microRNAs in vivo with 'antagomirs' | Q27860891 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Loss of heterozygosity at 13q14 and 13q21 in high grade, high stage prostate cancer | Q28211530 | ||
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia | Q28279141 | ||
Cancer cell cycles | Q29547756 | ||
Cancer statistics, 2006 | Q29615133 | ||
MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells | Q29616080 | ||
MicroRNA-133 controls cardiac hypertrophy | Q29616572 | ||
Delineation of prognostic biomarkers in prostate cancer | Q29617971 | ||
MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation | Q34212635 | ||
Advances in prostate cancer chemotherapy: a new era begins. | Q36258531 | ||
Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype | Q36309713 | ||
Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT. | Q38319485 | ||
RAKE and LNA-ISH reveal microRNA expression and localization in archival human brain | Q38439681 | ||
'Advanced' generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. | Q40655750 | ||
Genetic alterations in prostate cancer cell lines detected by comparative genomic hybridization | Q41065941 | ||
Androgen responsive adult human prostatic epithelial cell lines immortalized by human papillomavirus 18. | Q41107142 | ||
Both ERK and Wnt/beta-catenin pathways are involved in Wnt3a-induced proliferation | Q42472178 | ||
Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences | Q44491759 | ||
A phase II, pharmacokinetic, and biological correlative study of oblimersen sodium and docetaxel in patients with hormone-refractory prostate cancer | Q46493707 | ||
RNAi-mediated gene silencing in non-human primates. | Q53630565 | ||
Limiting the location of a putative human prostate cancer tumor suppressor gene at chromosome 13q14.3. | Q73283461 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | prostate cancer | Q181257 |
P304 | page(s) | 1271-7 | |
P577 | publication date | 2008-11-01 | |
P1433 | published in | Nature Medicine | Q1633234 |
P1476 | title | The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities | |
P478 | volume | 14 |